Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/14/2003US20030153049 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153045 Methods and compositions for protein expression and purification
08/14/2003US20030153042 Expression of functional eukaryotic proteins
08/14/2003US20030153041 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
08/14/2003US20030153040 Central nervous system disorders; antiinflammatory agents; antidiabetic agents; anticancer agents; hybrid polynucleotide
08/14/2003US20030153038 Method for in vitro molecular evolution of antibody function
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153035 Isolated nucleic acids; human or veterinary medicine
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153028 Cell isolation method
08/14/2003US20030153025 Cell-based drug screens for regulators of gene expression
08/14/2003US20030153020 Classification of signal of peptidoglycan; drug screening
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030152996 Method for nucleotide sequencing
08/14/2003US20030152992 Measuring fluorescence polarization
08/14/2003US20030152991 Transduction of protein
08/14/2003US20030152989 Genetic engineering; therapy for liver disease; antitumor agents
08/14/2003US20030152988 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescent dyes
08/14/2003US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/14/2003US20030152984 Biosynthsis; polymerase chain reactions
08/14/2003US20030152983 Desaturase
08/14/2003US20030152982 Method for the detection of the antibiotic resistance spectrum of Mycobacterium species
08/14/2003US20030152981 Detection of chromosome disease; enzyme digestion of Dna
08/14/2003US20030152976 Binding peptide library from skin/hair with an anti-target from hair/skin to form complex
08/14/2003US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
08/14/2003US20030152974 Isolation of nucleic acids on surfaces
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
08/14/2003US20030152963 Comprises peroxisome proliferator activated receptors; for treating accompanying conditions such as obesity, retinal degeneration, and disorders affecting the nervous system, heart, and/or kidneys
08/14/2003US20030152962 Comprises assay for expression of SCIP gene (transcription factor having suppressed cAMP inducible POU domains); screening neurotoxicology/neuropathology
08/14/2003US20030152961 Comprises bonded surface layer having both postive and negative charges for use in automatic sequence determination
08/14/2003US20030152958 Nucleic acid fragment-fixed electrode and its use
08/14/2003US20030152957 Probe-immobilized reaction arrays
08/14/2003US20030152956 Modulating gene expression of carboxypeptidase M, cathepsin C, endothelin-A receptor, and/or osteoblast specific factor by stimulating respiratory tract epithelial cells with interleukins; drug screening
08/14/2003US20030152955 Scanning genomes for long terminal repeat sequences; genetic mapping; gene knockout
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152952 Methylation analysis using nicking agents
08/14/2003US20030152951 Genotyping interleukin (IL-4) alleles in DNA/RNA
08/14/2003US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152946 Bh4-fused polypeptides
08/14/2003US20030152945 Drosophila gene mutations (open reading frames) disrupt mitosis and/or meiosis
08/14/2003US20030152944 For PCR mutagenesis with archael/error-prone DNA polymerases lacking exonuclease activity
08/14/2003US20030152943 Method for generating recombinant dna library using unidirectional single-stranded dna fragments
08/14/2003US20030152938 Microarray detects mismatch mutations
08/14/2003US20030152937 Increasing discriminating capability of hybridization assays via combination of labelled primers which replicate one strand of a nucleic acid having complementary capture probe
08/14/2003US20030152936 High pressure liquid chomatography to detect mutations
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152928 In situ hybridization of tissue or cell sample with probe for mRNA
08/14/2003US20030152925 Annealing control primer system for regulating primer annealing specificity and its applications
08/14/2003US20030152917 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains
08/14/2003US20030152914 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
08/14/2003US20030152912 Multiple viral replicon culture systems
08/14/2003US20030152592 Genetic engineering hybrid protein
08/14/2003US20030152590 Virion protein; induce immunology response; genetic engineered Dna
08/14/2003US20030152589 Infecting with bacteriophage; inducting immunology response; forming antibodies
08/14/2003US20030152583 Dna which codes complex
08/14/2003US20030152582 CTL epitopes from EBV
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152575 Using antiidiotypeic antibodies; anticancer, antitumor antibodies
08/14/2003US20030152574 Modulate nucleic acid gene expression
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152553 Transfection, transduction of cells
08/14/2003US20030152550 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003US20030152514 Methods for using anti-MUC18 antibodies
08/14/2003US20030150739 Electrospraying solutions of substances for mass fabrication of chips and libraries
08/14/2003CA2697599A1 Method of treating and preventing bone loss
08/14/2003CA2492032A1 Gene expression analysis using nicking agents
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475447A1 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475358A1 Method for producing methacrylic acid and acrylic acid with a combination of enzyme catalysts
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475326A1 A continuous cell line for the production of vaccines
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475276A1 Zinc finger libraries
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475235A1 Production process of recombinant placental growth factor
08/14/2003CA2475231A1 Generation of multiple embryo maize
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003CA2475095A1 Degradation of hydrophobic ester pesticides and toxins
08/14/2003CA2475094A1 Esterases with lipase activity
08/14/2003CA2474957A1 Methods for specific rapid detection of pathogenic food-relevant bacteria
08/14/2003CA2474939A1 Methods for modifying plant responses to stress and correspondingly derived plants
08/14/2003CA2474916A1 Digital amplification for detection of mismatch repair deficient tumor cells
08/14/2003CA2474806A1 Automatic threshold setting and baseline determination for real-time pcr
08/14/2003CA2474800A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003CA2474709A1 Immunostimulatory, covalently lipidated oligonucleotides
08/14/2003CA2474652A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003CA2474446A1 A method for the diagnosis of lymphoproliferative diseases
1 ... 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 ... 4023